UB Paderborn / Katalog / Suche / in CDI

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?

Cardiovascular drugs and therapy, 2021-12, Vol.35 (6), p.1183-1190

2021

Volltextzugriff (PDF)

Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes

Cardiovascular drugs and therapy, 2020-02, Vol.34 (1), p.53-63

2020

Volltextzugriff (PDF)

Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis

Platelets (Edinburgh), 2022-08, Vol.33 (6), p.879-886

2022

Volltextzugriff (PDF)

Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices

Platelets (Edinburgh), 2022-02, Vol.33 (2), p.249-256

2022

Volltextzugriff (PDF)

Antibodies against complement-regulatory proteins on platelets in immune thrombocytopenia

Platelets (Edinburgh), 2017-05, Vol.28 (4), p.409-413

2017

Volltextzugriff (PDF)

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices

Pharmaceuticals (Basel, Switzerland), 2022-04, Vol.15 (4), p.484

2022

Volltextzugriff (PDF)

Interleukin-6 and asymmetric dimethylarginine are associated with platelet activation after percutaneous angioplasty with stent implantation

PloS one, 2015-03, Vol.10 (3), p.e0122586-e0122586

2015

Volltextzugriff (PDF)

Underlying mechanism and specific prevention of hemolysis-induced platelet activation

Platelets (Edinburgh), 2017-08, Vol.28 (6), p.555-559

2017

Volltextzugriff (PDF)

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome

Journal of clinical medicine, 2023-02, Vol.12 (4), p.1627

2023

Volltextzugriff (PDF)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting

Frontiers in cardiovascular medicine, 2020-12, Vol.7, p.605669-605669

2020

Volltextzugriff (PDF)

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors

Research and practice in thrombosis and haemostasis, 2019-07, Vol.3 (3), p.383-390

2019

Volltextzugriff (PDF)

Thrombin-induced platelet activation across distinct stages of portal hyperension and cirrhosis

Journal of hepatology, 2022-07, Vol.77, p.S362-S363

2022

Volltextzugriff (PDF)

Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis

Hepatology (Baltimore, Md.), 2023-12

2023

Volltextzugriff (PDF)

Decreased platelet function is an independent predictor of liver-related and all-cause mortality in patients with advanced chronic liver disease

Journal of hepatology, 2023-06, Vol.78, p.S246

2023

Volltextzugriff (PDF)

WED-338 - Decreased platelet function is an independent predictor of liver-related and all-cause mortality in patients with advanced chronic liver disease

Journal of hepatology, 2023-06, Vol.78, p.S246-S246

2023

Volltextzugriff (PDF)

Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity

Vascular pharmacology, 2021-02, Vol.136, p.106819-106819, Article 106819

2021

Volltextzugriff (PDF)

Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome

Thrombosis and haemostasis, 2021-07, Vol.121 (7), p.913

2021

Volltextzugriff (PDF)

Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis

Thrombosis and haemostasis, 2016-03, Vol.115 (3), p.615

2016

Volltextzugriff (PDF)

Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) and Pak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodies

Clinical chemistry and laboratory medicine, 2015-10, Vol.53 (11), p.1779

2015

Volltextzugriff (PDF)

Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices

Thrombosis and haemostasis, 2023-03, Vol.123 (3), p.336

2023

Volltextzugriff (PDF)

Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis

Thrombosis and haemostasis, 2017-01, Vol.117 (1), p.90

2017

Volltextzugriff (PDF)

Impact of variables of the P-selectin - P-selectin glycoprotein ligand-1 axis on leukocyte-platelet interactions in cardiovascular disease

Thrombosis and haemostasis, 2015-04, Vol.113 (4), p.806

2015

Volltextzugriff (PDF)

Sex differences of leukocyte–platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis

Atherosclerosis, 2014-12, Vol.237 (2), p.692-695

2014

Volltextzugriff (PDF)

Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia

Thrombosis research, 2023-03, Vol.223, p.102-110

2023

Volltextzugriff (PDF)

Plasma Levels of snoRNAs are Associated with Platelet Activation in Patients with Peripheral Artery Disease

International journal of molecular sciences, 2019-11, Vol.20 (23), p.5975

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?

Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes

Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis

Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices

Antibodies against complement-regulatory proteins on platelets in immune thrombocytopenia

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices

Interleukin-6 and asymmetric dimethylarginine are associated with platelet activation after percutaneous angioplasty with stent implantation

Underlying mechanism and specific prevention of hemolysis-induced platelet activation

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors

Thrombin-induced platelet activation across distinct stages of portal hyperension and cirrhosis

Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis

Decreased platelet function is an independent predictor of liver-related and all-cause mortality in patients with advanced chronic liver disease

WED-338 - Decreased platelet function is an independent predictor of liver-related and all-cause mortality in patients with advanced chronic liver disease

Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity

Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome

Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis

Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) and Pak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodies

Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices

Decreased platelet reactivity in patients with cancer is associated with high risk of venous thromboembolism and poor prognosis

Impact of variables of the P-selectin - P-selectin glycoprotein ligand-1 axis on leukocyte-platelet interactions in cardiovascular disease

Sex differences of leukocyte–platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis

Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia

Plasma Levels of snoRNAs are Associated with Platelet Activation in Patients with Peripheral Artery Disease

Suchergebnisse filtern